MACRAMÉ Partner Spotlight: MyBiotech GmBH
MyBiotech GmbH is a dynamic CDMO headquartered in Germany offering end-to-end development, manufacturing services, and cutting‑edge products for the biotechnology and pharmaceutical sectors. …
MyBiotech GmbH is a dynamic CDMO headquartered in Germany offering end-to-end development, manufacturing services, and cutting‑edge products for the biotechnology and pharmaceutical sectors. …
Continuing the NanoHarmony NANOMET journey: Harmonisation & Standardisation of Test Methodsfor Nanomaterials and Advanced Materials– Where did our research projects get us, and where do we go from here? *** ONLINE *** 3rd & 4th November 2025 The Horizon Europe projects MACRAMÉ, iCARE, nanoPASS and DESIDERATA invite you to an exclusive Read more
MACRAMÉ Experts used the opportunity to provide feedback in the commenting phase of the revision of the Safe and Sustainable by Design Chemicals and Materials Framework.
Seven Past Nine GmbH (7P9-DE) is a micro-company dedicated to advancing data stewardship across collaborative scientific research projects and, as the name suggests, a sister company of the Slovenian Seven Past Nine d.o.o. (7P9-SI). The driving force behind the company’s vision for harmonised data management is Thomas Exner, the founder Read more
The ‘Joint Risk Assessor Summit on Advancing Safety & Sustainability Assessments of Advanced Materials’ hosted by ACCORDs, iCARE, MACRAMÉ, and nanoPASS, was a full success. To address new challenges for safety and sustainability assessment coming with advanced materials, the EU Horizon Europe projects ACCORDs, iCARE, MACRAMÉ, and nanoPASS hosted the Read more
The development of new approach methodologies (NAMs) to replace current in vivo testing for the safety assessment of engineered nanomaterials (ENMs) is hindered by the scarcity of validated experimental data for many ENMs. MACRAMÉ partners contributed to the publication ‘Wisdom of Crowds for Supporting the Safety Evaluation of Nanomaterials’.
MACRAMÉ colleagues from EMPA have published a study on Data-Driven Prediction of Nanoparticle Biodistribution from Physicochemical Descriptors.
MACRAMÉ colleagues from EMPA and Epithelix have published a paper entitled ‘Silicon Carbide Nanowires Impair Mucociliary Clearance-Mediated Innate Immunity in Primary Human Bronchial Epithelial Cells’. In this study, the fate of zero-dimensional, one-dimensional, and two-dimensional silicon- and carbon-based nanomaterials was investigated for the first time.
The MACRAMÉ Project team has published an Innovation Report about its Project’s R&I approach. In the paper entitled ‘MACRAMÉ – Advanced characterisation methodologies to assess and predict the health and environmental risks of advanced materials‘, the authors describe the planned information-flow between the different R&I activities conducted in the Project (see Read more
FILK Freiberg Institute gGmbH is an industrial research institution with focus on research and development for small and medium-sized enterprises (SMEs). The history of the institute starts in 1889 with focus on the leather and tanning industry. …